Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
16.43
+0.15 (+0.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neogenomics Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
March 29, 2022
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 29, 2022
Gainers IGM Biosciences (NASDAQ:IGMS) shares rose 114.8% to $32.2 during Tuesday's regular session. IGM Biosciences's stock is trading at a volume of 31.6 million...
Via
Benzinga
Stocks Higher as Ukraine-Russia Peace Talks Advance
March 29, 2022
Optimism is high on Wall Street, as peace talks between Ukraine and Russia seem to advance.
Via
Talk Markets
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
March 29, 2022
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.
Via
Benzinga
Why Is NeoGenomics (NEO) Stock Down Today?
March 29, 2022
Cancer-testing company NeoGenomics is down more than 30% today after lowering earnings expectations. How far will NEO stock fall?
Via
InvestorPlace
NeoGenomics Stock Gets Downgrade After CEO Resigns And Other Negative Updates
March 29, 2022
NeoGenomics, Inc.
Via
Benzinga
NeoGenomics Stock Tanks After CEO Exits Amid Sales, Profitability Maelstrom
March 29, 2022
Shares were hammered after NeoGenomics pulled its full-year outlook.
Via
Investor's Business Daily
Twilio Insider Trading Scandal: 8 Things for TWLO Stock Investors to Know
March 29, 2022
Twilio (TWLO) stock is on the move Tuesday as the U.S. Securities and Exchange Commission (SEC) weighs in on an insider trading scandal.
Via
InvestorPlace
36 Stocks Moving In Tuesday's Mid-Day Session
March 29, 2022
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
March 29, 2022
From
The Schall Law Firm
Via
Business Wire
Why NeoGenomics Stock Is Plunging Today
March 29, 2022
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 29, 2022
On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; McCormick Profit Beats Estimates
March 29, 2022
U.S. stocks opened on a strong note on Tuesday, with the Dow jumping around 350 points this morning.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
March 29, 2022
Upgrades
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
March 29, 2022
BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 29, 2022
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 45.0% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $8.5 million.
Via
Benzinga
Where NeoGenomics Stands With Analysts
March 29, 2022
Over the past 3 months, 8 analysts have published their opinion on NeoGenomics (NASDAQ:NEO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
March 29, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) rose 40.1% to $21.00 in pre-market trading following announcement of collaboration with Sanofi (NASDAQ: SNY). Guardforce AI Co.,...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 29, 2022
Good morning! It's time to start another busy day of trading with another breakdown of the biggest pre-market stock movers on Tuesday!
Via
InvestorPlace
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
March 28, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ALERT - Labaton Sucharow Investigating NeoGenomics Inc. - NEO
March 28, 2022
From
Labaton Sucharow LLP
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
March 28, 2022
Gainers NexImmune (NASDAQ:NEXI) stock moved upwards by 8.3% to $3.51 during Monday's after-market session. This security traded at a volume of 109.1K shares come close, making up 76.6% of its average...
Via
Benzinga
NeoGenomics Announces CEO Departure and Initiates CEO Search
March 28, 2022
Board Appoints Executive Chair and Interim Office of the CEO Anticipates First Quarter Results Below Guidance and Withdraws 2022 Guidance FT. MYERS, FL / ACCESSWIRE / March 28, 2022 / NeoGenomics, Inc....
From
NeoGenomics, Inc.
Via
AccessWire
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
March 17, 2022
Study further highlights potential of RaDaR to stratify patients and improve treatment outcomes FT. MYERS, FL / ACCESSWIRE / March 17, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of...
From
NeoGenomics, Inc.
Via
AccessWire
NeoGenomics Earnings Perspective: Return On Capital Employed
March 14, 2022
NeoGenomics (NASDAQ:NEO) brought in sales totaling $125.73 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 105.22%, resulting in a loss...
Via
Benzinga
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
March 02, 2022
FT MYERS, FL / ACCESSWIRE / March 2, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...
From
NeoGenomics, Inc.
Via
AccessWire
10 Biggest Price Target Changes For Thursday
February 24, 2022
SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading.
Via
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.